Icecure Medical is trading 5.77% up at $1.10 on October 16, 2026; no company-specific announcement explaining the pre-market move has surfaced. - The latest company release, on October 13, highlighted ProSense clinical data and physician engagement at EUSOBI 2026. - The move aligns with healthcare-sector strength as investors rotate to defensive assets amid inflation and interest-rate concerns. - Broader reporting describes a risk-off market and healthcare’s relative resilience, but does not directly attribute the gain to that trend.